Terns Pharmaceuticals (430.F) Q3 2024 Earnings

Aug 5Confirmed
Q4 2023
Q2 2024
Q3 2024
-0.32
-0.3
-0.28
-0.27

Details

Expected EPS
-0.30952774159999996
Actual EPS
-0.282968
Surprise EPS
0.03
Surprise Percent
+8.58%

Description

⁨Terns Pharmaceuticals⁩ (⁦430.F⁩) has reported earnings of ⁦-0.282968⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts